Mydecine Innovations Group (MYCOF) Stock Price, News & Analysis

Company Overview

Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: $0.0034 to $0.0062
• 50-Day Range: N/A
• 52-Week Range: $0.0007 to $0.0160
• Volume: 2,284 shs
• Average Volume: 11,029 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MYCOF Stock Analysis - Frequently Asked Questions

How have MYCOF shares performed this year?

Mydecine Innovations Group's stock was trading at $0.0028 at the start of the year. Since then, MYCOF shares have increased by 21.4% and is now trading at $0.0034.
View the best growth stocks for 2025 here.

How were Mydecine Innovations Group's earnings last quarter?

Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) issued its earnings results on Tuesday, November, 16th. The company reported ($1.00) EPS for the quarter, missing analysts' consensus estimates of ($0.50) by $0.50.

When did Mydecine Innovations Group's stock split?

Mydecine Innovations Group shares reverse split before market open on Thursday, April 21st 2022. The 1-50 reverse split was announced on Thursday, April 21st 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, April 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

How do I buy shares of Mydecine Innovations Group?

Shares of MYCOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 11/16/2021
• Today: 5/16/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Candy & Soda
• Current Symbol: OTCMKTS:MYCOF
• CIK: N/A
• Web: www.mydecine.com
• Phone: (604) 687-2038
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A